Abstract
A new polycyclic tetramate macrolactam designated allostreptamide (1), together with four known congeners, were isolated from the culture extract of Allostreptomyces RD068384. The planar structure of the new compound was elucidated through interpretation of NMR and MS data. The absolute configuration was determined through ROESY and ECD analyses. The isolated compounds revealed antifungal potential against fourteen Candida albicans isolates with minimum inhibitory concentrations (MICs) ranging from 64 to 2048 µg ml-1. Compound 3 showed antibiofilm action and considerably reduced the viability of five isolates (36%) in the formed biofilm. The qRT-PCR revealed that 3 downregulated the BCR1, PLB2, ALS1, and SAP5 biofilm related gene expression. Therefore, 3 could be a promising antifungal therapy for C. albicans infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ding L, Zhang S-D, Haidar AK, Bajimaya M, Guo Y, Larsen TO, et al. Polycyclic tetramate macrolactams–a group of natural bioactive metallophores. Front Chem. 2021;9:772858.
Jomon K, Kuroda Y, Ajisaka M, Sakai H. A new antibiotic, ikarugamycin. J Antibiot. 1972;25:271–80.
Graupner P, Thornburgh S, Mathieson J, Chapin E, Kemmitt G, Brown J, et al. Dihydromaltophilin; a novel fungicidal tetramic acid containing metabolite from Streptomyces sp. J Antibiot. 1997;50:1014–9.
Yu F, Zaleta-Rivera K, Zhu X, Huffman J, Millet JC, Harris SD, et al. Structure and biosynthesis of heat-stable antifungal factor (HSAF), a broad-spectrum antimycotic with a novel mode of action. Antimicrob Agents Chemother. 2007;51:64–72.
Zhang G, Zhang W, Zhang Q, Shi T, Ma L, Zhu Y, et al. Mechanistic insights into polycycle formation by reductive cyclization in ikarugamycin biosynthesis. Angew Chem Int Ed. 2014;53:4840–4.
Shigemori H, Bae MA, Yazawa K, Sasaki T, Kobayashi J. Alteramide A, a new tetracyclic alkaloid from a bacterium Alteromonas sp. associated with the marine sponge Halichondria okadai. J Org Chem. 1992;57:4317–20.
Saha S, Zhang W, Zhang G, Zhu Y, Chen Y, Liu W, et al. Activation and characterization of a cryptic gene cluster reveals a cyclization cascade for polycyclic tetramate macrolactams. Chem Sci. 2017;8:1607–12.
Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans–the virulence factors and clinical manifestations of infection. J Fungi. 2021;7:79.
Cavalheiro M, Teixeira MC. Candida biofilms: threats, challenges, and promising strategies. Front Med. 2018;5:28.
Vitiello A, Ferrara F, Boccellino M, Ponzo A, Cimmino C, Comberiati E, et al. Antifungal drug resistance: an emergent health threat. Biomedicines. 2023;11:1063.
Huang M-J, Rao MPN, Salam N, Xiao M, Huang H-Q, Li W-J. Allostreptomyces psammosilenae gen. nov., sp. nov., an endophytic actinobacterium isolated from the roots of Psammosilene tunicoides and emended description of the family Streptomycetaceae [Waksman and Henrici (1943) AL] emend. Rainey et al. 1997, emend. Kim et al. 2003, emend. Zhi et al. 2009. Int J Syst Evol Microbiol. 2017;67:288–93.
Sahu AK, Quadri SR, Agasar D, Ruwaili JA, Jun-Li W, Dastager SG. Allostreptomyces indica sp. nov., isolated from India. J Antibiot. 2017;70:1000–3.
Suga T, Kimura T, Inahashi Y, Iwatsuki M, Nonaka K, Také A, et al. Hamuramicins A and B, 22-membered macrolides, produced by an endophytic actinomycete Allostreptomyces sp. K12-0794. J Antibiot 2018;71:619–25.
Xu L, Wu P, Wright SJ, Du L, Wei X. Bioactive polycyclic tetramate macrolactams from Lysobacter enzymogenes and their absolute configurations by theoretical ECD calculations. J Nat Prod. 2015;78:1841–7.
Hou L, Liu Z, Yu D, Li H, Ju J, Li W. Targeted isolation of new polycyclic tetramate macrolactams from the deepsea-derived Streptomyces somaliensis SCSIO ZH66. Bioorg Chem. 2020;101:103954.
Blodgett JA, Oh D-C, Cao S, Currie CR, Kolter R, Clardy J. Common biosynthetic origins for polycyclic tetramate macrolactams from phylogenetically diverse bacteria. Proc Nat Acad Sci USA. 2010;107:11692–7.
Li Y, Huffman J, Li Y, Du L, Shen Y. 3-Hydroxylation of the polycyclic tetramate macrolactam in the biosynthesis of antifungal HSAF from Lysobacter enzymogenes C3. MedChemComm. 2012;3:982–6.
Jin H, Zhang W, Zhang G, Zhang L, Liu W, Zhang C. Engineered biosynthesis of 5/5/6 type polycyclic tetramate macrolactams in an ikarugamycin (5/6/5 type)-producing chassis. Org Lett. 2020;22:1731–5.
Liu W, Zhang W, Jin H, Zhang Q, Chen Y, Jiang X, et al. Genome mining of marine-derived Streptomyces sp. SCSIO 40010 leads to cytotoxic new polycyclic tetramate macrolactams. Mar Drugs. 2019;17:663.
Kim D, Kim KY. Hedera rhombea inhibits the biofilm formation of Candida, thereby increases the susceptibility to antifungal agent, and reduces infection. PLoS ONE. 2021;16:e0258108.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Elsbaey, M., Samaru, Y., Elekhnawy, E. et al. A new polycyclic tetramate macrolactam from Allostreptomyces RD068384: stereochemistry and antifungal potential. J Antibiot 77, 393–396 (2024). https://doi.org/10.1038/s41429-024-00705-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-024-00705-7